Vyome Holdings, Inc
HIND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427570
No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Vyome Holdings, Inc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 18 | 16 | −2 |
| Shares | 266.5K | 387.9K | +121.5K (+45.6%) |
| Value | $49.1K | $73.3K | +$24.2K (+49.2%) |
New holders (3)
Institutions that held Vyome Holdings, Inc at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 58,913 | $11.0K | 0.00% |
| HRT Financial LP | 19,646 | $3.00K | 0.00% |
| Bank of America Corp | 192 | $37 | 0.00% |
Sold out (5)
Institutions that held Vyome Holdings, Inc at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Millennium Management LLC | 29,785 | $5.49K |
| Goldman Sachs Group Inc | 23,036 | $4.25K |
| Jane Street Group, LLC | 22,926 | $4.23K |
| Two Sigma Securities, LLC | 12,820 | $2.36K |
| Wells Fargo & Company | 183 | $34 |